Post Marketing Surveillance of Nintedanib in Indian Patients With Idiopathic Pulmonary Fibrosis

CompletedOBSERVATIONAL
Enrollment

21

Participants

Timeline

Start Date

April 5, 2017

Primary Completion Date

July 21, 2022

Study Completion Date

July 21, 2022

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG

Nintedanib

Nintedanib

DRUG

Pirfenidone

Pirfenidone

Trial Locations (8)

226003

King George Medical University, Lucknow

226006

Midland Healthcare and Research Centre, Lucknow

302039

Asthma Bhawan, Jaipur

400007

Bhatia Hospital, Mumbai

400016

P.D. Hinduja National Hospital, Mumbai

411001

Grant Medical Foundation, Ruby Hall Clinic, Pune

700017

National Allergy Asthma Bronchitis Institute, Kolkata, Kolkata

700027

CK Birla Hospitals, The Calcutta Medical Research Institute, Kolkata

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY